abivertinib: Clinical Trials

2 trials of abivertinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown, 1 withdrawn. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Unknown 1, Withdrawn 1

Follow abivertinib: new trials by email Literature Review of abivertinib trials Research Report on abivertinib

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation
Abivertinib Maleate Capsules, Placebo Gefitinib Tablets, Gefitinib Tablets - Advanced Non-small Cell Lung Cancer
Phase 3UnknownHangzhou ACEA Pharmaceutical Research Co., Ltd.4062019-03-012019-02-27
A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI
Pemetrexed, Cisplatin 75mg/m2, AC0010 - NSCLC
Phase 3WithdrawnHangzhou ACEA Pharmaceutical Research Co., Ltd.2018-12-012019-02-04

Sponsors

Hangzhou ACEA Pharmaceutical Research Co., Ltd. (2)

Countries

China (2)

Top investigators

Yilong Wu, MD (1)  ·  Yuankai Shi, MD. (1)